Correspondence to editorials on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial"
Clin Mol Hepatol. 2024 Nov 11.
doi: 10.3350/cmh.2024.0989.
Online ahead of print.
1 Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
2 Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.